Analysts forecast that HMS Holdings Corp (NASDAQ:HMSY) will announce $156.14 million in sales for the current quarter, according to Zacks. Six analysts have issued estimates for HMS’s earnings, with estimates ranging from $155.20 million to $157.00 million. HMS reported sales of $148.49 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 5.2%. The company is scheduled to report its next earnings report on Friday, February 22nd.
On average, analysts expect that HMS will report full year sales of $598.53 million for the current financial year, with estimates ranging from $597.60 million to $600.00 million. For the next year, analysts expect that the business will post sales of $636.79 million, with estimates ranging from $625.10 million to $658.00 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for HMS.
HMS (NASDAQ:HMSY) last posted its earnings results on Friday, November 2nd. The business services provider reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.10. The company had revenue of $154.20 million for the quarter, compared to the consensus estimate of $140.93 million. HMS had a return on equity of 10.63% and a net margin of 8.01%. The firm’s revenue for the quarter was up 22.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.19 earnings per share.
Shares of NASDAQ:HMSY traded down $0.77 during mid-day trading on Thursday, reaching $34.43. The stock had a trading volume of 712,274 shares, compared to its average volume of 532,633. The company has a current ratio of 4.04, a quick ratio of 4.04 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $3.00 billion, a P/E ratio of 80.07, a P/E/G ratio of 3.83 and a beta of 1.34. HMS has a 1 year low of $14.88 and a 1 year high of $38.15.
In other HMS news, Chairman William C. Lucia sold 45,035 shares of the company’s stock in a transaction that occurred on Friday, November 30th. The stock was sold at an average price of $35.35, for a total transaction of $1,591,987.25. Following the sale, the chairman now directly owns 207,605 shares in the company, valued at $7,338,836.75. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Teresa South sold 2,800 shares of the company’s stock in a transaction that occurred on Friday, November 23rd. The shares were sold at an average price of $35.69, for a total value of $99,932.00. Following the sale, the executive vice president now owns 103,024 shares in the company, valued at $3,676,926.56. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 688,645 shares of company stock worth $24,027,123. Company insiders own 4.54% of the company’s stock.
Hedge funds have recently modified their holdings of the business. First Quadrant L P CA purchased a new stake in HMS during the third quarter valued at approximately $107,000. BlueMountain Capital Management LLC purchased a new stake in HMS during the third quarter valued at approximately $146,000. Ibex Investors LLC purchased a new stake in HMS during the third quarter valued at approximately $210,000. Jackson Financial Management purchased a new stake in HMS during the third quarter valued at approximately $242,000. Finally, CAPROCK Group Inc. purchased a new stake in HMS during the third quarter valued at approximately $246,000. Institutional investors and hedge funds own 93.93% of the company’s stock.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
Featured Article: Investing strategies using the yield curve
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.